# Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

> **NCT07437404** · PHASE3 · RECRUITING · sponsor: **Sinocelltech Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Haemophilia A

## Interventions

- **DRUG:** SCT800 prophylaxis and treatment for bleeding events

## Key facts

- **NCT ID:** NCT07437404
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-26
- **Primary completion:** 2028-12-26
- **Final completion:** 2028-12-26
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07437404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07437404, "Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07437404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*